Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

vesnarinone

Known as: 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2-1H-quinolinone, vesnarinone [Chemical/Ingredient], 3,4-Dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-pip- erazinyl)- 2(1H)-quinolinone 
A cardiotonic quinolinone derivative, that suppresses cell proliferation and induces apoptosis by inducing the expression of p21, an inhibitor of… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain. We… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Previous reports have shown that elevated circulating levels of cytokines and/or cytokine receptors predict adverse… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Vesnarinone, a cardiotonic agent, blocks I(Kr) and, unlike other I(Kr) blockers, produces a frequency-dependent prolongation of… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A BSTRACT Background Vesnarinone, an inotropic drug, was shown in a short-term placebo-controlled trial to improve survival… Expand
  • figure 1
  • figure 2
  • table 4
Is this relevant?
2000
2000
OBJECTIVES This study sought to evaluate the effects of postmenopausal estrogen use on mortality in aging women with congestive… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Background Vesnarinone, an inotropic drug, was shown in a short-term placebo-controlled trial to improve survival markedly in… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Vesnarinone, an inotropic drug, was shown in a short-term placebo-controlled trial to improve survival markedly in… Expand
Is this relevant?
1994
1994
BACKGROUND Vesnarinone, a quinolinone derivative, is a recently synthesized positive inotropic agent that has been shown to… Expand
  • figure 1
  • figure 2
Is this relevant?
1994
1994
Controversy still exists concerning the therapy for viral myocarditis which manifests a wide variety of clinical symptoms… Expand
  • figure 1
  • figure 2
  • table I
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND Inotropic therapy, other than with digitalis glycosides, has had limited success in patients with chronic congestive… Expand
Is this relevant?